CASC3 and Miyoshi myopathy: Additionally, stromal cells in the MM tumor microenvironment help MM cells develop drug resistance and prolong MM cell survival, but we found that nanoencapsulated BTZ and BCMA-targeted BTZ-NP therapy could overcome this effect of the stromal microenvironment.